CapForce IBD 50 ETF (FFTY)

The CapForce IBD 50 ETF (FFTY) gives retail investors access to a curated list of fifty stocks that Investors’ Business Daily, a financial newspaper and research firm, identifies as displaying strong fundamental and technical characteristics — growth-oriented names, proven earnings momentum, and stock price strength. It is a simplified way to participate in a stock-picking thesis without hiring an active fund manager: the fund holds the same fifty names the index holds, rebalances quarterly when the index does, and charges a modest expense ratio. The fund exists for investors who believe that systematic screening for quality and momentum can beat the broader market, and who want that exposure in a liquid, low-cost wrapper.

What question does this fund try to answer?

IBD publishes a stock-picking framework built on decades of analysis of big stock market winners. The core question it addresses is simple: are there observable patterns — in earnings growth, revenue acceleration, profit margins, relative price strength, and industry strength — that predict which mid-cap stocks will outperform? The IBD 50 index reflects the answer: yes. It selects fifty names that rank highly across IBD’s screening criteria, updating the list quarterly as companies’ fundamentals and price action change. FFTY is the transparent vehicle for that thesis. An investor buying FFTY is betting that these fifty screened names will deliver returns above a diversified index like the S&P 500, by virtue of their superior momentum and quality signals.

How the index is built and maintained

The IBD 50 operates under a clear, repeatable process. Candidates must meet minimum liquidity and market-cap thresholds to be eligible, then are scored on five broad dimensions: the earnings-growth trajectory (how fast earnings have been rising), the relative strength of the stock price compared to the broader market, the industry group it belongs to (does that sector offer tailwinds?), the quality of recent revenue growth, and institutional buying activity (are mutual funds and pensions accumulating the stock?). The fifty highest-scoring companies form the index. The list changes throughout the year as positions are added and removed, with a formal quarterly rebalance. FFTY holds whatever fifty stocks are in the index at any rebalancing date, adjusted for corporate actions such as splits and mergers.

This differs from a traditional cap-weighted index like the S&P 500, where a company’s weight is determined by how large it is. In IBD 50, the holdings are equally weighted — each of the fifty stocks is given the same percentage of the fund at rebalancing. This equal-weight scheme amplifies the impact of the smaller companies in the index and makes the fund more reactive to the screening process itself.

Costs, liquidity, and structure

FFTY is a straightforward exchange-traded fund — not a leveraged product, not an inverse fund, not a structured note. It holds fifty actual stocks, settles on the secondary market like any stock, and can be bought or sold during trading hours at market prices. The expense ratio is competitive for an actively managed concept (though less expensive than hiring a dedicated manager), and the fund holds enough assets and trading volume that investors entering or exiting large positions face reasonable spreads.

Because the fund rebalances quarterly, turnover is moderate — the fifty names do not turn over completely each quarter, but neither are they held unchanged for years. Investors in FFTY will see regular capital gains distributions as the underlying stocks appreciate and are sold during rebalancing; those gains are typically short-term rather than long-term, because the holding period for many names is measured in months rather than years. Tax efficiency is not FFTY’s strongest suit; investors in taxable accounts should plan for annual distributions.

The risks and the honest trade-offs

A fifty-stock portfolio, even one screened for quality, is less diversified than an index fund holding hundreds or thousands. Concentration risk is real: if the momentum and growth factors that the IBD framework prizes fall out of favor (as they periodically do), FFTY will underperform. During years when the market rewards large-cap, low-volatility, or mature dividend-payers over high-growth names, the fund tends to lag.

Equal weighting adds another layer of risk. By resetting each position to the same weight at each rebalancing, the fund automatically sells winners and buys losers within the index. This “rebalancing drag” can be beneficial over very long periods, but it also means the fund does not let best performers run; a ten-bagger in the index will be trimmed back to equal weight, costing the fund the outsized gains.

Finally, the IBD 50’s screening is backward-looking. It identifies companies that have already shown strong earnings growth and price momentum. By definition, those signals tell you something about the recent past; they do not guarantee the future. The fund is best understood as a bet that mean reversion is weak — that this year’s winners will remain winners next year — rather than a guarantee that the screening criteria predict future returns.

Who this fund is for and how to approach it

FFTY appeals to investors who believe in factor-based investing, who have conviction in the IBD framework, or who want a moderate-cap growth tilt without the fees of an active mutual fund. It is not appropriate as a core holding for passive diversification; a total-market index fund is simpler and cheaper for that role. Instead, FFTY works as a satellite position for investors willing to accept higher volatility in exchange for the possibility of outperformance, or for those who want to test the IBD thesis with real money at reasonable cost.

Research should begin with the index’s methodology, published on the IBD website and often summarized in the fund’s prospectus. Compare FFTY’s long-term returns to the S&P 500 and to other growth-focused ETFs, paying attention to periods when it lagged — those will reveal when its screening criteria worked against it. Check the turnover ratio and the holding period of the most recent rebalance to understand tax impact. And watch the current composition: a quick scan of which fifty stocks are in the index at any moment tells you whether they skew toward certain sectors (technology, healthcare, financials), which matters for understanding your own portfolio’s composition.